𝔖 Bobbio Scriptorium
✦   LIBER   ✦

The p53 and mdm-2 genes in human testicular germ-cell tumors

✍ Scribed by Guy Riou; Michel Barrois; Sandrine Prost; Marie Josée Terrier; Christine Theodore; Arnold J. Levine


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
645 KB
Volume
12
Category
Article
ISSN
0899-1987

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Mutations in the p53 gene are common in many cancers. They have been documented to occur in about 55% of all cancers of 51 different cell and tissue types. These mutations are accompanied by overexpression of the p53 protein in the nucleus of the cell, and this protein has lost its tumor suppressor function. In this study, 25 testicular germ‐cell (TGC) tumors were tested for p53 mutations and the level of p53 protein expression. While 67% of the tumors overproduced the p53 protein in the nucleus of 10‐60% of their cells, in all cases the DNA sequence of exons 4‐9 of the p53 gene was wild type. In this tumor type, there was apparently no selection pressure for p53 mutations. The mdm‐2 gene resides on chromosome 12 (12q13‐q14), a chromosome often altered in TGC tumors. mdm‐2 gene amplification (2.5‐ to 10‐fold) was detected in three (12%) of these TGC tumors. These three tumors, and eight additional TGC tumors, overexpressed mdm‐2 mRNA. There was a good correlation between overexpression of p53 protein and overexpression of mdm‐2 mRNA (P = 0.01). This may well result from the fact that the level of mdm‐2 mRNA is regulated by the p53 level. These studies demonstrate that TGC tumors fail to be selected for p53 mutations but nonetheless frequently expressed high levels of wild‐type p53 protein in the cell nucleus. Perhpas this produces the excellent response to radiation and chemotherapy of these tumors, which generally have a good prognosis. Wild‐type p53 may mediate apoptosis in these cells in response to the DNA damage. © 1995 Wiley‐Liss Inc.


📜 SIMILAR VOLUMES


Genes, chromosomes and the development o
✍ Alan McIntyre; Duncan Gilbert; Neil Goddard; Leendart Looijenga; Janet Shipley 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 296 KB 👁 1 views

## Abstract Testicular germ cell tumors (TGCTs) of adults and adolescents are thought to be derived from primordial germ cells or gonocytes. TGCTs develop postpuberty from precursor lesions known as intratubular germ cell neoplasia undifferentiated. The tumors can be divided into two groups based o

Overexpression of MDM-2 mRNA and mutatio
✍ Ya-Tse Cheng; Yu-Ling Li; Jeng Dau Wu; Shih-Bin Long; Tzong-Shin Tzai; Ching-Che 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 840 KB

## Abstract To investigate the importance of oncogenes and tumor suppressor genes in bladder carcinogenesis, we determined the status of the expression of the __MDM‐2__ and __p53__ genes and genetic alterations in the __p53__ gene in five bladder carcinoma cell lines and one kidney urothelial carci

Testicular germ cell tumors in patients
✍ Marcus U. Hentrich; Norbert G. Brack; Peter Schmid; Tobias Schuster; Christoph C 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 813 KB

## BACKGROUND. There has been evidence of a higher incidence of testicular germ cell tumors (GCT) in human immunodeficiency virus (HlV)-seropositive men than in the non HIV-infected male population. Most authors recommend standard therapy for HIV-positive patients with GCT but the immunosuppressive

p53 Protein alterations in human testicu
✍ Jir̂ina Bártkov´; Jir̂í Bártek; Jir̂ina Lukáŝ; Bor̂ivoj Vojtêŝek; Zdenka Staŝkov 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 942 KB

Expression of the p53 oncoprotein was examined in a wide range of primary human testicular germ-cell tumours using a new mouse monoclonal antibody (MAb) BP53-I I raised and characterized in this study, in parallel with a polyclonal rabbit antiserum CM-I. lmmunohistochemistry on paraffin sections sho